Biblio
Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway. Cell Rep. 2024;43(4):114065.
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis. N Engl J Med. 2024;390(16):1467-1480.
Hydrogel-based microenvironment engineering of haematopoietic stem cells. Cell Mol Life Sci. 2023;80(2):49.
.